Literature DB >> 194931

Myocardial imaging with Cc-99m pyrophosphate in patients on adriamycin treatment for neoplasia.

A K Chacko, D H Gordon, J M Bennett, R E O'Mara, G A Wilson.   

Abstract

Technetium-99m pyrophosphate was utilized for myocardial imaging in 15 patients on adriamycin treatment for neoplasia. We have noted abnormal accumulation of the pyrophosphate in several patients, particularly in those in whom the so-called poor-risk factors were operative, namely prior radiation, cyclophosphamide therapy, and ischemic heart disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194931

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Myocardial scintigraphy with infarct-avid tracers.

Authors:  B L Holman; J Wynne
Journal:  Cardiovasc Radiol       Date:  1979-09

Review 2.  Drug interactions with radiopharmaceuticals.

Authors:  S Hesslewood; E Leung
Journal:  Eur J Nucl Med       Date:  1994-04

3.  Infarct avid imaging study in the radionuclide diagnosis of acute myocardial infarction.

Authors:  R L van Heertum
Journal:  Bull N Y Acad Med       Date:  1981-11

4.  Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate.

Authors:  A M al-Nahhas; S Jinnouchi; C Anagnostopoulos; W Hirsch; T Heary; V R McCready
Journal:  Eur J Nucl Med       Date:  1995-02

5.  Positive myocardial scintigraphy at the bedside--evaluation using a portable gamma camera.

Authors:  D S Dymond; P H Jarritt; K E Britton; D Langley; R A Spurrell
Journal:  Postgrad Med J       Date:  1978-10       Impact factor: 2.401

6.  Scintigraphic evaluation of myocardial uptake of thallium 201 and technetium 99m pyrophosphate utilizing a rat model of chronic doxorubicin cardiotoxicity.

Authors:  M Miyagawa; S Tanada; K Hamamoto
Journal:  Eur J Nucl Med       Date:  1991
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.